Markets

Health care stocks fell Monday but outperformed most other sectors, with the NYSE Health Care Index sinking 1.0% and the SPDR Health Care Select Sector ETF (XLV) down 1.1%. The iShares Biotechnology ETF (IBB) also was sinking 2.3%.

In company news, Dermata Therapeutics (DRMA) plunged as much as 63% to touch a new record low of $0.22 a share after Monday saying its DMT310 drug candidate did not produce a statistically significant separation in patients with moderate to severe rosacea compared with patients who received a placebo during phase 2 testing.